Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 4/2017

09.11.2016 | Original Research

Impact of Increased Visceral Fat Measured by CT on Colon Adenocarcinoma Stage

verfasst von: Ahmad Mahamid, Itamar Ashkenazi, Mika Shapira-Rootman, Oded Olsha, Ricardo Alfici, Eliahu Y Bekhor, Isis Abo- Mouch, Abdel-Rauf Zeina

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Obesity is considered a risk factor for colon cancer. Worse outcome observed in colon cancer patients with obesity may have several mechanisms. However, the influence of obesity on colon cancer stage is yet to be clarified. The objective of this study was to determine the relationship between obesity and stage on presentation.

Methods

This is a retrospective analysis of patients’ files in one university affiliated medical center. Included in this study were non-metastatic patients who underwent colectomy for adenocarcinoma of the colon in whom both the preoperative abdominal computed tomography and the postoperative pathology report were available for evaluation. Abdominal computed tomography measurement of retroperitoneal fat thickness was used as an indicator of obesity. Data was analyzed according to quartiles of fat thickness.

Results

Of 83 patients, 38 were males and 45 were females. Median age was 71 years (range 43–90 years). Increased retroperitoneal fat thickness was not associated with advanced T and N stages on presentation. Rather, patients in the first quartile presented with the worst T and N stages. The proportion of patients with T3 and T4 tumors was 95, 76.2, 66.7, and 66.7% in quartiles 1, 2, 3, and 4, respectively (p = 0.0327), while the proportion of patients with positive lymph node metastasis was 60, 23.8, 23.8, and 42.9% in quartiles 1, 2, 3, and 4, respectively (p = 0.0319).

Conclusions

The data presented here does not support the association of obesity with worse stage at presentation of colon cancer, and other possible mechanisms for worse outcome should be sought.
Literatur
1.
2.
Zurück zum Zitat Edge S, Byrd DR, Compton C,C, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual, 7th edition. New York: Springer; 2010. Edge S, Byrd DR, Compton C,C, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual, 7th edition. New York: Springer; 2010.
3.
Zurück zum Zitat Caan BJ, Coates AO, Slattery ML, Potter JD, Quesenberry Jr CP, Edwards SM. Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord. 1998;22:178–84.CrossRefPubMed Caan BJ, Coates AO, Slattery ML, Potter JD, Quesenberry Jr CP, Edwards SM. Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord. 1998;22:178–84.CrossRefPubMed
4.
Zurück zum Zitat Hou L, Ji BT, Blair A, Dai Q, Gao YT, Potter JD, et al. Body mass index and colon cancer risk in Chinese people: menopause as an effect modifi er. Eur J Cancer. 2006;42:84–90.CrossRefPubMedPubMedCentral Hou L, Ji BT, Blair A, Dai Q, Gao YT, Potter JD, et al. Body mass index and colon cancer risk in Chinese people: menopause as an effect modifi er. Eur J Cancer. 2006;42:84–90.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control. 2003;14:75–84.CrossRefPubMed Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control. 2003;14:75–84.CrossRefPubMed
6.
Zurück zum Zitat Haydon AM, Macinnis RJ, English DR, Giles GG. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut. 2006;55:62–7.CrossRefPubMedPubMedCentral Haydon AM, Macinnis RJ, English DR, Giles GG. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut. 2006;55:62–7.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Almendingen K, Hofstad B, Vatn MH. Does high body fatness increase the risk of presence and growth of colorectal adenomas followed up in situ for 3 years? Am J Gastroenterol. 2001;96:2238–46.CrossRefPubMed Almendingen K, Hofstad B, Vatn MH. Does high body fatness increase the risk of presence and growth of colorectal adenomas followed up in situ for 3 years? Am J Gastroenterol. 2001;96:2238–46.CrossRefPubMed
8.
Zurück zum Zitat DeFronzo RA, Ferrannini E. Insulin resistance—a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atheroschlerotic cardiovascular disease. Diabetes Care. 1991;14:174–94. DeFronzo RA, Ferrannini E. Insulin resistance—a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atheroschlerotic cardiovascular disease. Diabetes Care. 1991;14:174–94.
10.
Zurück zum Zitat Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Japan Public Health Center-based Prospective Study Group. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study. Int J Cancer. 2007;120:2007–12.CrossRefPubMed Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S. Japan Public Health Center-based Prospective Study Group. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study. Int J Cancer. 2007;120:2007–12.CrossRefPubMed
11.
Zurück zum Zitat Larsson SC, Rutegård J, Bergkvist L, Wolk A. Physical activity, obesity, and risk of colon and rectal cancer in a cohort of Swedish men. Eur J Cancer. 2006;42:2590–7.CrossRefPubMed Larsson SC, Rutegård J, Bergkvist L, Wolk A. Physical activity, obesity, and risk of colon and rectal cancer in a cohort of Swedish men. Eur J Cancer. 2006;42:2590–7.CrossRefPubMed
12.
Zurück zum Zitat Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995;122:327–34.CrossRefPubMed Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995;122:327–34.CrossRefPubMed
13.
Zurück zum Zitat Isomura K, Kono S, Moore MA, Toyomura K, Nagano J, Mizoue T, et al. Physical activity and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci. 2006;97:1099–104.CrossRefPubMed Isomura K, Kono S, Moore MA, Toyomura K, Nagano J, Mizoue T, et al. Physical activity and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci. 2006;97:1099–104.CrossRefPubMed
14.
Zurück zum Zitat House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M, et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg. 2008;12:270–8.CrossRefPubMed House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M, et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg. 2008;12:270–8.CrossRefPubMed
15.
Zurück zum Zitat Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res. 2010;16:1884–93.CrossRefPubMedPubMedCentral Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res. 2010;16:1884–93.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Demark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt JA, et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomark Prev. 2012;21(8):1244–59.CrossRef Demark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt JA, et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomark Prev. 2012;21(8):1244–59.CrossRef
17.
Zurück zum Zitat Bjørndal B, Burri L, Staalesen V, Skorve J, Berge RK. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obesity. 2011;15:2011. Bjørndal B, Burri L, Staalesen V, Skorve J, Berge RK. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obesity. 2011;15:2011.
18.
Zurück zum Zitat Keimling M, Renehan AG, Behrens G, Fischer B, Hollenbeck AR, Cross AJ, et al. Comparison of associations of body mass index, abdominal adiposity, and risk of colorectal cancer in a large prospective cohort study. Cancer Epidemoil Biomarkers Prev. 2013;22(8):1383–94.CrossRef Keimling M, Renehan AG, Behrens G, Fischer B, Hollenbeck AR, Cross AJ, et al. Comparison of associations of body mass index, abdominal adiposity, and risk of colorectal cancer in a large prospective cohort study. Cancer Epidemoil Biomarkers Prev. 2013;22(8):1383–94.CrossRef
19.
20.
Zurück zum Zitat Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson 3rd AB, Macdonald JS, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer. 2003;98:484–95.CrossRefPubMed Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson 3rd AB, Macdonald JS, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer. 2003;98:484–95.CrossRefPubMed
Metadaten
Titel
Impact of Increased Visceral Fat Measured by CT on Colon Adenocarcinoma Stage
verfasst von
Ahmad Mahamid
Itamar Ashkenazi
Mika Shapira-Rootman
Oded Olsha
Ricardo Alfici
Eliahu Y Bekhor
Isis Abo- Mouch
Abdel-Rauf Zeina
Publikationsdatum
09.11.2016
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 4/2017
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-016-9891-8

Weitere Artikel der Ausgabe 4/2017

Journal of Gastrointestinal Cancer 4/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.